<ѻý>New Bispecific Antibody Approved for Tough-to-Treat Lymphomaѻý> Approval of glofitamab was based on a phase I/II study that showed a 56% overall response rate Jun 16, 2023
<ѻý>Cystic Renal Masses Often Harbor High-Grade Diseaseѻý> No link between grade and cancer-specific survival, active surveillance still an option for many Jun 16, 2023
<ѻý>Early Invasive Breast Cancer Now Leaves Mostly Long-Term Survivorsѻý> Mortality risk has decreased substantially since the 1990s Jun 15, 2023
<ѻý>Pushback on Price Negotiation; Genetic Testing Lags; More Foreign Help for Shortagesѻý> News, features, and commentary about cancer-related issues Jun 15, 2023
<ѻý>Base-Edited CAR-T Product 'Potent' in Relapsed Childhood T-Cell ALLѻý> One young patient achieved molecular remission within 28 days of infusion Jun 14, 2023
<ѻý>Pre-Existing Depression, Anxiety Tied to Worse DLBCL Prognosisѻý> Patients with depression alone had the worst overall survival Jun 13, 2023
<ѻý>CRISPR Therapy Exceeds Targets in Thalassemia, Sickle Cell Diseaseѻý> Results "indicate that exa-cel can provide a one-time functional cure," says researcher Jun 13, 2023
<ѻý>Breast Ultrasound Recs May Not Be Targeting the Right Womenѻý> It's not just dense breasts that matter, researchers say Jun 12, 2023
<ѻý>CAR-T for Chronic Lymphocytic Leukemia Hits Goal of Mid-Stage Trialѻý> All patients had progressed on BTK inhibitors and most had failed venetoclax Jun 12, 2023
<ѻý>Hooray! A Clearer Estimate of Your Risk for Death Is Hereѻý> Researchers do the legwork to incorporate smoking status into NCI's "Know Your Chances" website Jun 09, 2023
<ѻý>TTFields Therapy Yields OS Improvement in Second-Line NSCLCѻý> However, device was not tested alongside current standard of care, expert points out Jun 08, 2023
<ѻý>How Vax Skeptics Sow Doubt; Gun Death Every 11 Minutes; 90210 Star's Cancer Spreadsѻý> Health news and commentary from around the Web gathered by ѻý staff Jun 08, 2023
<ѻý>Studies Question Role of CDK4/6 Inhibitors in First-Line Advanced Breast Cancerѻý> No PFS, OS benefit with first-line versus second-line CDK4/6 inhibition, more toxicity, cost Jun 07, 2023
<ѻý>Skipping Radiotherapy 'Seems Safe' for PMBCL Patients in Remissionѻý> PET-negative patients after chemoimmunotherapy fared well with observation alone Jun 07, 2023
<ѻý>FGFR Inhibitor Stakes Claim to Post-Anti-PD-1 Role in Advanced Bladder Cancerѻý> Survival benefit supports FGFR testing for all patients with metastatic disease, researcher says Jun 07, 2023
<ѻý>Checkpoint Blockade Stumbles in Advanced EGFR-Mutant NSCLCѻý> "Immediate changes" needed to patient care to avoid unnecessary toxicity, says ASCO expert Jun 07, 2023
<ѻý>Certain NSCLC Patients May Be Able to Stop Immunotherapy at 2 Yearsѻý> Retrospective study finds no difference in OS between patients who stop and those who continue Jun 06, 2023
<ѻý>No Survival Benefit With Immune Checkpoint Inhibitor Rechallenge in Metastatic RCCѻý> The strategy also led to increased toxicity Jun 06, 2023
<ѻý>New Data in NSCLC Bolster Support for Perioperative Immunotherapyѻý> EFS benefit with pembrolizumab in KEYNOTE-671, but no OS benefit "yet," says investigator Jun 05, 2023
<ѻý>Second-Line Axi-Cel Bests Standard in Relapsed/Refractory Large B-Cell Lymphomaѻý> The CAR T-cell therapy led to significantly longer overall survival Jun 05, 2023
<ѻý>New Agents for Relapsed/Refractory Myeloma Impress in Early-Stage Clinical Trialsѻý> High rates of deep, durable response with bispecific antibody, rapidly produced CAR T-cell agents Jun 05, 2023
<ѻý>CAR-T Tops Standard Care in Heavily Pretreated Lenalidomide-Refractory Myelomaѻý> Ciltacabtagene autoleucel improved progression-free survival versus two standard triplets Jun 05, 2023
<ѻý>Omitting RT Safe in Many Locally Advanced Rectal Cancersѻý> Most intermediate-risk cases can be cured without pelvic radiation, says investigator Jun 05, 2023
<ѻý>Novel IDH1/2 Inhibitor Shows 'Dramatic Effect' in Low-Grade Gliomaѻý> INDIGO data demonstrate that some patients can delay "toxic" chemo and radiation, says expert Jun 04, 2023
<ѻý>Nivolumab-AVD Boosts PFS in Untreated Hodgkin Lymphomaѻý> SWOG trial had goal of "harmonizing" treatment in adults, children with advanced-stage disease Jun 04, 2023
<ѻý>New Standard in Operable EGFR-Positive Lung Cancerѻý> "We should firmly close the door on one-size-fits-all treatment," says ASCO expert Jun 04, 2023
<ѻý>How a Medical Recoding May Limit Cancer Patients’ Options for Breast Reconstructionѻý> Many believe this would restrict women's options for surgery Jun 04, 2023
<ѻý>New Ovarian Cancer Drug Extends Survival in Resistant Diseaseѻý> "Practice changing" findings for tough-to-treat patient population Jun 04, 2023
<ѻý>Neoadjuvant Chemo Flops Versus Upfront Surgery for Resectable Pancreatic Cancerѻý> Survival 13 months better with surgery, but "curiosities" in neoadjuvant arm muddy the results Jun 04, 2023
<ѻý>Novel Anti-HER2 Drugs 'Impressive' in Advanced Biliary Cancerѻý> Response rates reached 41-47% with different approaches in rare disease Jun 03, 2023
<ѻý>Chemo-Free Approach Works in Subset of Patients With HER2+ Early Breast Cancerѻý> Impressive 3-year invasive DFS seen with adaptive response strategy using FDG-PET Jun 03, 2023
<ѻý>Pricey Drug Combo Boosts PFS in First-Line Advanced Ovarian Cancerѻý> Questions about anti-PD-L1 contribution, cost, and access to durvalumab, bevacizumab, olaparib Jun 03, 2023
<ѻý>De-Escalated Surgery Suffices for Low-Risk Cervical Cancerѻý> Simple hysterectomy non-inferior to radical operation Jun 02, 2023
<ѻý>CDK4/6 Extends Reach Into Early-Stage Breast Cancerѻý> Addition of ribociclib to endocrine therapy boosts disease-free survival in high-risk disease Jun 02, 2023
<ѻý>Adaptive RT Fails to Relieve Dry Mouth in Head and Neck Cancerѻý> "Expensive and intensive" process does not translate into clinical benefit, researchers conclude Jun 01, 2023
<ѻý>No Access to Routine Healthcare Biggest Barrier to HPV Vaccinationѻý> Retrospective analysis shows vaccination rates haven't much improved for women since 2015 May 25, 2023
<ѻý>Medicaid Expansion Tied to Better Outcomes in Black Patients With GI Cancersѻý> Two-year mortality decreased for three types of GI cancer in expansion vs non-expansion states May 25, 2023
<ѻý>Less-Invasive Surgery for Pancreatic Cancer Proves Safe, Effectiveѻý> Radical resection rate noninferior to open surgery in early-stage disease, with similar survival May 25, 2023
<ѻý>Monoclonal Antibody Reduced Need For Transfusions in Low-Risk MDSѻý> Results suggest a "paradigm shift" in the treatment of anemia for these patients May 25, 2023
<ѻý>Cross-Border Collaboration Improves Survival in Pediatric Leukemia Patientsѻý> 5-year OS increased to 100% in standard-risk ALL patients at a Tijuana hospital May 25, 2023